Join
Live feed
·
PRReleasevia Quantisnow
aTyr Pharma Inc. logo

aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

ByQuantisnow·Wall Street's wire, on your screen.
ATYR· aTyr Pharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATYR (aTyr Pharma Inc.) and more on Quantisnow.